CompletedNot applicableNCT05194033

Efficacy and Safety of Oral Lactobacillus Plantarum GUANKE (CGMCC NO.21720) in Enhancement of Antibody Level After SARS-CoV-2 Vaccination (Trial 1)

Studying Severe acute respiratory syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Peking University
Principal Investigator
Yangfeng Wu
Peking University
Intervention
Probiotics daily(dietary_supplement)
Enrollment
31 target
Eligibility
18-59 years · All sexes
Timeline
20222022

Study locations (2)

Collaborators

Centers for Disease Control and Prevention, China · Beijing Pinggu District Hospital · Peking University Health Science Center Hospital

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05194033 on ClinicalTrials.gov

Other trials for Severe acute respiratory syndrome

Additional recruiting or active studies for the same condition.

See all trials for Severe acute respiratory syndrome

← Back to all trials